MBX Biosciences, Inc. Common Stock (MBX) Earnings
MBX Biosciences, Inc. Common Stock is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-0.84. MBX has beaten EPS estimates in 5 of its last 7 reported quarters (average surprise +7.6% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-0.84 · Revenue est —
Track record
Beat EPS in 5 of 7 quarters
Avg surprise +7.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 13, 2026 | $-0.63 | $-0.78 | -23.3% | — | — |
| May 14, 2026 | $-0.62 | $-0.51 | +17.7% | — | — |
| Mar 12, 2026 | $-0.63 | $-0.49 | +22.2% | — | — |
| Nov 6, 2025 | $-0.73 | $-0.63 | +13.7% | — | — |
| Aug 7, 2025 | $-0.77 | $-0.58 | +24.7% | — | — |
| Mar 17, 2025 | $-0.59 | $-0.47 | +20.3% | — | — |
| Nov 7, 2024 | $-2.72 | $-2.78 | -2.2% | — | — |
| Dec 31, 2023 | — | $-0.26 | — | — | — |
| Sep 30, 2023 | — | $-0.32 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.